Asia Pacific NIPAH Virus Diagnostics Market, By Test Type (RT-PCR v/s ELISA), By Sample (Throat & Nasal Swab, Urine, Blood, Others), By End User (Hospitals & Clinics, Diagnostics Laboratories, Others) By Country, Competition Forecast & Opportunities, 2028
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationAsia Pacific NIPAH Virus Diagnostics Market, By Test Type (RT-PCR v/s ELISA), By Sample (Throat & Nasal Swab, Urine, Blood, Others), By End User (Hospitals & Clinics, Diagnostics Laboratories, Others) By Country, Competition Forecast & Opportunities, 2028
Asia Pacific NIPAH virus diagnostics market is projected to boom in the upcoming five years while exhibiting an impressive CAGR. In the last five years from 2018 to 2022, the market has experienced quite a growth that was counted in millions of sales and is anticipated to project its growth in the forecast period, 2024-2028 on the account of increasing demand for early diagnostics of the NIPAH virus.
NIPAH virus is a strain of zoonotic virus that spreads among animals and humans likewise. The virus has the tendency to transmit from animals to humans. The outbreak of COVID-19 virus is the most recent and major example of NIPAH virus effect on the human life. The virus is also known to cause illness in pigs and people. It is associated with the disease called encephalitis that is swelling of the brain. The adverse effect of this virus may cause death. During an outbreak, standard infection control practices can help prevent person-to-person spread in hospital settings.
Some of the major players in the Asia Pacific NIPAH virus diagnostics market include Abbott Laboratories, Roche Diagnostics, Bio-Rad Laboratories, Thermo Fisher Scientific, and Qiagen N.V. These companies are investing heavily in research and development activities to develop new and advanced diagnostic tools for NIPAH virus detection. Additionally, the Asia Pacific NIPAH virus diagnostics market is also characterized by the presence of local players who cater to the specific needs of the region. For instance, Indian companies such as J Mitra & Co. and BioMerieux India are offering cost-effective diagnostic solutions to the local market. In addition to diagnostics, the Asia Pacific region is also witnessing an increase in the development of therapeutics and vaccines for NIPAH virus. Several pharmaceutical companies are working on the development of vaccines and antiviral drugs to combat the virus.
Moreover, the growing number of government initiatives aimed at controlling the spread of NIPAH virus is also contributing to the growth of NIPAH Virus Diagnostics market in the Asia Pacific region. For example, the Indian government has launched several awareness campaigns and implemented strict control measures to prevent the spread of the virus. These efforts are driving demand for diagnostic tests which in turn rises the growth of Asia Pacific NIPAH Virus Diagnostic Market.
COVID-19 Surged Demand for NIPAH Virus Diagnostics
Recent conditions of the pandemic surged the demand for the diagnosis and identification of adverse effects of the virus among bats and then in the human population. The outbreak of coronavirus although was not related to COVID-19 but the NIPAH virus upsurged due to the outbreak. In countries like India and China, etc. the virus added to the infection and death counts that increased during the pandemic. Demand for the early diagnostic and effective and efficient testing along with the treatment aided the growth of the Asia Pacific NIPAH virus diagnostics market in the upcoming five years. Government authorities further stepped-up contact tracing efforts, identifying, quarantining, and testing people who may have meet the victims, thereby supporting the growth of the Asia Pacific NIPAH virus diagnostics market in the future five years.
Increasing incidence of NIPAH virus cases
The Asia Pacific region has seen a significant increase in the number of NIPAH virus cases in recent years. According to the World Health Organization (WHO), between 2001 and 2018, there were 596 reported cases of NIPAH virus in the region, with a case fatality rate of approximately 40%. This has led to an increased demand for accurate and efficient diagnostics tools for early detection and treatment of the disease.With the increasing incidence of NIPAH virus cases, there is also a growing awareness of the disease among healthcare professionals and the general public. This has led to an increased demand for diagnostics tools and has also prompted governments to invest in healthcare infrastructure and research and development activities to combat the disease.
Increasing Number of Testing Kits Support Market Growth
Research institutes and market players are actively involved in introducing effective testing kits for the identification of the NIPAH virus infections. The surge in the demand for the early diagnostics is driving the demand for the innovative and effective testing kits such that market is also expected to aid the growth of the Asia Pacific NIPAH virus diagnostics market in the next five years. Increasing incidences of the diseases caused by the NIPAH virus is further aiding the growth of the Asia Pacific NIPAH virus diagnostics market in the upcoming five years. Increased commercialization of the testing kit is also supporting the growth of the Asia Pacific NIPAH virus diagnostics market in the future five years.
Technological Advancements Aid Market Growth
Since the outbreak of NIPAH virus is very sudden, consistent research and technological advancement towards formulating better diagnostic kits and treatment procedure is a must. Due to sudden outbreaks, there is sudden increase in demand for diagnostic kits. Early diagnostics and then the treatment for the virulent infection creates demand for the technologically advanced NIPAH virus testing kits, thereby supporting the growth of the Asia Pacific NIPAH virus diagnostics market in the next five years.
The NIPAH virus belongs to the class of Paramyxoviridae viruses. The World Health Organization (WHO) has put forth a 5-year framework for identifying the virus strains and formulate strategies to create a set up where earliest diagnostic kits can be organized. These steps are taken for the consideration towards reducing death and morbidity rates that starts to rise with the immediate spread of NiV virus. The development of new and advanced diagnostic technologies is also driving growth in the Asia Pacific NIPAH virus diagnostics market. Rapid diagnostic tests, which can provide results in minutes, are becoming increasingly popular, as they allow for quick and easy diagnosis of NIPAH virus infections in the field. Additionally, advances in molecular diagnostic techniques, such as PCR (polymerase chain reaction), are improving the accuracy and sensitivity of NIPAH virus detection and leads to the development of Asia Pacific NIPAH Virus Diagnostic Market.
Lack of awareness and knowledge regarding NIPAH Virus
One of the major restraining factors for the Asia Pacific NIPAH virus diagnostics market is the lack of awareness and knowledge about NIPAH virus infection. Many people in the region are still unaware of the disease, its symptoms, and the potential risks associated with it. This lack of knowledge and awareness leads to a delay in seeking medical attention, which can worsen the condition of the patient and increase the risk of transmission. Therefore, it will give rise to the growth of Asia Pacific NIPAH Virus Diagnostic Market.
Market Segmentation
The Asia Pacific NIPAH virus diagnostics market is segmented based on test type, sample, end user, competitional landscape, and country analysis. Based on test type, the market is further fragmented into RT PCR, and ELISA. Based on sample, the market is segmented into throat & nasal swab, urine, blood, and others. Based on end user, the market is further segmented into hospitals & clinics, diagnostics laboratories, and others. The market analysis also studies the country analysis segmentation to devise country-based share segmentation analyzing, China, India, Japan, South Korea, Australia, Bangladesh, Myanmar, Singapore, Philippines, and Thailand.
Company Profile
A partial list of major shareholders of the Asia Pacific NIPAH virus diagnostics market includes, Molbio Diagnostics Pvt. Ltd., Krishgen Biosystems, MyBioSource, Inc., Liferiver Bio-Tech (United States) Corp, Roche Holding AG, Vivacure Limited, Siegfried AG, Aurobindo Pharma, Minapharm Pharmaceuticals, Starlake Bioscience Co. The market players are actively involved in the extended research related to various equipment, services, and researching the market to substantiate the growth of the Asia-Pacific NIPAH virus diagnostic market.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2022 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
| Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | · Test Type · Sample · End User · Region · Company |
| Country Scope | China, India, Japan, South Korea, Australia, Bangladesh, Myanmar, Singapore, Philippines, and Thailand |
| Key Companies Profiled | Molbio Diagnostics Pvt. Ltd., Krishgen Biosystems, MyBioSource, Inc., Liferiver Bio-Tech (United States) Corp, Roche Holding AG, Vivacure Limited, Siegfried AG, Aurobindo Pharma, Minapharm Pharmaceuticals, Starlake Bioscience Co. |
| Customization Scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy